PANBELA THERAPEUTICS INC (PBLA)

US69833W4042 - Common Stock

1.11  -0.12 (-9.76%)

After market: 1.04 -0.07 (-6.31%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-9-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
23.79M34.09M10.01M5.75M4.32M
Research and Development
18.00M28.05M5.42M2.51M2.35M
Selling, General, and Administrative Expenses
5.80M6.04M4.59M3.25M1.97M
Operating Income
-23.79M-34.09M-10.01M-5.75M-4.32M
Interest Income/Expense
-310.00K-270.00K-10.00K-20.00K-2.19M
Other Income/Expense
-10.00K-680.00K-600.00K610.00K-100.00K
Non Recurring Items
N/AN/A0.00100.00KN/A
Income Before Taxes
-23.71M-35.05M-10.62M-5.06M-6.62M
Income Tax
-180.00K-120.00K-490.00K-300.00K-420.00K
Net Income
-23.53M-34.93M-10.14M-4.77M-6.20M
 
Per Share Data
EPS Diluted Total Ops
-170.68-1.75K-1.01K-476.99-1.31K
Non GAAP EPS
-4.01K-5.80K-25.83N/AN/A
 
Statistics

All data in USD

Charts